Answers are grounded in this paper and cite their sources.
Demonstrates endothelial dysfunction induced by polystyrene nanoplastics, suggesting implications for cardiovascular health.
Background The presence of micro- and nanoplastics (MNPLs) in human blood raises concerns about their vascular impact and their potential contribution to cardiovascular diseases. Endothelial cells are a primary target of circulating MNPLs; however, the molecular and functional consequences of this exposure remain largely undefined. Methods In this study, we exposed primary human umbilical vein endothelial cells (HUVECs) to carboxylated polystyrene nanoplastics (PS-NPLs; 30, 50, and 100 nm) and integrated RNA sequencing with targeted functional assays. Results Transcriptomics revealed a robust response characterized by coordinated dysregulation of cholesterol homeostasis, genotoxic stress and DNA repair, inflammatory signaling, and endothelial plasticity (endothelial-to-mesenchymal transition). Guided by these signatures, functional assays confirmed increased intracellular cholesterol, DNA damage, remodelling of migratory capacity and angiogenic behaviour, and reduced IL-6 secretion. Discussion Overall, the concordance between transcriptomic programs and functional endpoints supports a mechanistic framework in which PS-NPL exposure rewires endothelial metabolic and stress-response networks, with downstream consequences for key vascular functions. Differences across the nanoscale range modulated the magnitude and temporal profile of specific endpoints, but the shared molecular core response predominated across treatments.
No takes yet. Share an insight, caveat, or question.
Martín-Pérez et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: